Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

A clinical practice guideline for female patients with hormone receptor–positive breast cancer. The guideline examines the use of adjuvant endocrine therapy, particularly with tamoxifen. Outcomes of interest include reduced recurrence improved mortality with extended tamoxifen therapy.